Boosted Profits from Core Blasting Operations and Advancements in Technology and Digital Solutions

Solid Earnings Growth Driven by Core Business and Technological Advancements Highlights of the First Half of 2024: Orica, a global leader in blasting solutions, reported significant financial achievements in the first half of 2024. Key highlights include: CEO’s Perspective: Sanjeev…

Read MoreBoosted Profits from Core Blasting Operations and Advancements in Technology and Digital Solutions

Orica and Kinross Collaborate on ‘Enhancing Safety and Efficiency in Blasting Operations’

In a recent discussion highlighted in Global Mining Review, Orica’s Washington Vilas Boas, specializing in Technical Services in Blasting Engineering, and Lucas Steffen from Kinross Gold’s Morro do Ouro mine in Brazil, shared insights into how Orica’s WebGen™ wireless initiating…

Read MoreOrica and Kinross Collaborate on ‘Enhancing Safety and Efficiency in Blasting Operations’

Introducing Tirzepatide for Obesity: Approval Submission and Marketing Alliance Announcement in Japan

Eli Lilly Japan K.K. (headquartered in Kobe, Hyogo; led by Representative Director and President Simone Thomsen, hereinafter referred to as “Eli Lilly Japan”) and Mitsubishi Tanabe Pharma Corporation (headquartered in Osaka, Osaka; led by Representative Director Akihiro Tsujimura, hereinafter referred…

Read MoreIntroducing Tirzepatide for Obesity: Approval Submission and Marketing Alliance Announcement in Japan

Santen and Mitsubishi Tanabe Pharma Collaborate for Joint Sales Promotion of Alesion® Eyelid Cream 0.5% in Japan, Introducing a Novel Allergic Conjunctivitis Treatment

Santen Pharmaceutical Co., Ltd. (based in Osaka, henceforth referred to as Santen) and Mitsubishi Tanabe Pharma Corporation (also based in Osaka, henceforth referred to as Mitsubishi Tanabe Pharma) have recently inked a collaboration agreement aimed at jointly promoting Alesion® Eyelid…

Read MoreSanten and Mitsubishi Tanabe Pharma Collaborate for Joint Sales Promotion of Alesion® Eyelid Cream 0.5% in Japan, Introducing a Novel Allergic Conjunctivitis Treatment

Arkema and ProLogium Partner to Develop Next-Generation Lithium Ceramic Battery Materials for E-Mobility

Arkema has been selected by ProLogium, a Taiwanese leader in advanced battery technology, as a crucial development and supply partner for its upcoming gigafactory in France. On May 14th, Arkema and ProLogium held a letter of intent (LOI) exchange ceremony…

Read MoreArkema and ProLogium Partner to Develop Next-Generation Lithium Ceramic Battery Materials for E-Mobility

Arkema Completes Acquisition of Dow’s Flexible Packaging Laminating Adhesives Division

Arkema has reached an agreement to acquire Dow’s flexible packaging laminating adhesives business, a major player in the adhesives sector for flexible packaging, with an annual revenue of approximately US$250 million. This strategic move is poised to significantly enhance Arkema’s…

Read MoreArkema Completes Acquisition of Dow’s Flexible Packaging Laminating Adhesives Division

Toray Develops Affordable, Eco-Friendly Film Packaging Compliant with EU Waste Regulations

Toray Industries, Inc., Dow Inc., Comexi Group Industries, S.A.U., Sakata Inx Corporation, and SGK Japan (Schawk Japan K.K.) have collaboratively developed a revolutionary surface printing mono-material film packaging technology. This innovation aligns with the European Union’s Packaging and Packaging Waste…

Read MoreToray Develops Affordable, Eco-Friendly Film Packaging Compliant with EU Waste Regulations

Toray Initiates European Clinical Trial for RAPROS® in Treating Feline Chronic Kidney Disease

Toray Industries, Inc. announced today the commencement of a clinical trial in Europe for RAPROS®, an oral treatment designed for chronic kidney disease (CKD) in cats. Feline CKD is a progressive condition that deteriorates kidney function, causing symptoms like appetite…

Read MoreToray Initiates European Clinical Trial for RAPROS® in Treating Feline Chronic Kidney Disease